Undertaking Decentralized Clinical Trials In The UK ‘Should Not Be A Luxury’

 
• By Vibha Sharma

UK needs to do more to address the current uncertainty among sponsors on how decentralized clinical trials can generate regulatory-grade data.

A hiker looking over a sea of clouds in the mountains at dawn.
UK Regulators Must Improve Visibility Around Their Position On Decentralized Trials • Source: Shutterstock

More from United Kingdom

More from Europe